Market shrugs-off GlaxoSmithKline's promising Omicron trial data
Shares in pharma group GlaxoSmithKline (GSK) were unmoved despite news of positive data for its Omicron Covid tests.Glaxo and partner Vir Biotechnology are working on a monoclonal antibody drug called Sotrovimab and latest data...
02 December 2021